{"pmid":32428114,"title":"Social media: friend or foe in the COVID-19 pandemic?","text":["Social media: friend or foe in the COVID-19 pandemic?","Clinics (Sao Paulo)","Lima, Diego Laurentino","Lopes, Maria Antonieta Albanez A de Medeiros","Brito, Ana Maria","32428114"],"journal":"Clinics (Sao Paulo)","authors":["Lima, Diego Laurentino","Lopes, Maria Antonieta Albanez A de Medeiros","Brito, Ana Maria"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32428114","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.6061/clinics/2020/e1953","weight":0,"_version_":1667252837772427267,"score":9.490897,"similar":[{"pmid":32340044,"title":"The ACE-2 in COVID-19: Foe or Friend?","text":["The ACE-2 in COVID-19: Foe or Friend?","COVID-19 is a rapidly spreading outbreak globally. Emerging evidence demonstrates that older individuals and people with underlying metabolic conditions of diabetes mellitus, hypertension, and hyperlipidemia are at higher risk of morbidity and mortality. The SARS-CoV-2 infects humans through the angiotensin converting enzyme (ACE-2) receptor. The ACE-2 receptor is a part of the dual system renin-angiotensin-system (RAS) consisting of ACE-Ang-II-AT1R axis and ACE-2-Ang-(1-7)-Mas axis. In metabolic disorders and with increased age, it is known that there is an upregulation of ACE-Ang-II-AT1R axis with a downregulation of ACE-2-Ang-(1-7)-Mas axis. The activated ACE-Ang-II-AT1R axis leads to pro-inflammatory and pro-fibrotic effects in respiratory system, vascular dysfunction, myocardial fibrosis, nephropathy, and insulin secretory defects with increased insulin resistance. On the other hand, the ACE-2-Ang-(1-7)-Mas axis has anti-inflammatory and antifibrotic effects on the respiratory system and anti-inflammatory, antioxidative stress, and protective effects on vascular function, protects against myocardial fibrosis, nephropathy, pancreatitis, and insulin resistance. In effect, the balance between these two axes may determine the prognosis. The already strained ACE-2-Ang-(1-7)-Mas in metabolic disorders is further stressed due to the use of the ACE-2 by the virus for entry, which affects the prognosis in terms of respiratory compromise. Further evidence needs to be gathered on whether modulation of the renin angiotensin system would be advantageous due to upregulation of Mas activation or harmful due to the concomitant ACE-2 receptor upregulation in the acute management of COVID-19.","Horm Metab Res","Dalan, Rinkoo","Bornstein, Stefan R","El-Armouche, Ali","Rodionov, Roman N","Markov, Alexander","Wielockx, Ben","Beuschlein, Felix","Boehm, Bernhard O","32340044"],"abstract":["COVID-19 is a rapidly spreading outbreak globally. Emerging evidence demonstrates that older individuals and people with underlying metabolic conditions of diabetes mellitus, hypertension, and hyperlipidemia are at higher risk of morbidity and mortality. The SARS-CoV-2 infects humans through the angiotensin converting enzyme (ACE-2) receptor. The ACE-2 receptor is a part of the dual system renin-angiotensin-system (RAS) consisting of ACE-Ang-II-AT1R axis and ACE-2-Ang-(1-7)-Mas axis. In metabolic disorders and with increased age, it is known that there is an upregulation of ACE-Ang-II-AT1R axis with a downregulation of ACE-2-Ang-(1-7)-Mas axis. The activated ACE-Ang-II-AT1R axis leads to pro-inflammatory and pro-fibrotic effects in respiratory system, vascular dysfunction, myocardial fibrosis, nephropathy, and insulin secretory defects with increased insulin resistance. On the other hand, the ACE-2-Ang-(1-7)-Mas axis has anti-inflammatory and antifibrotic effects on the respiratory system and anti-inflammatory, antioxidative stress, and protective effects on vascular function, protects against myocardial fibrosis, nephropathy, pancreatitis, and insulin resistance. In effect, the balance between these two axes may determine the prognosis. The already strained ACE-2-Ang-(1-7)-Mas in metabolic disorders is further stressed due to the use of the ACE-2 by the virus for entry, which affects the prognosis in terms of respiratory compromise. Further evidence needs to be gathered on whether modulation of the renin angiotensin system would be advantageous due to upregulation of Mas activation or harmful due to the concomitant ACE-2 receptor upregulation in the acute management of COVID-19."],"journal":"Horm Metab Res","authors":["Dalan, Rinkoo","Bornstein, Stefan R","El-Armouche, Ali","Rodionov, Roman N","Markov, Alexander","Wielockx, Ben","Beuschlein, Felix","Boehm, Bernhard O"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32340044","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1055/a-1155-0501","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138494297178112,"score":50.575645},{"pmid":32339534,"pmcid":"PMC7195096","title":"COVID-19 and diabetes: is metformin a friend or foe?","text":["COVID-19 and diabetes: is metformin a friend or foe?","Diabetes Res Clin Pract","Ursini, Francesco","Ciaffi, Jacopo","Paola Landini, Maria","Meliconi, Riccardo","32339534"],"journal":"Diabetes Res Clin Pract","authors":["Ursini, Francesco","Ciaffi, Jacopo","Paola Landini, Maria","Meliconi, Riccardo"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339534","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.diabres.2020.108167","e_drugs":["Metformin"],"topics":["Mechanism"],"weight":1,"_version_":1666138494182883330,"score":47.671585},{"pmid":32397487,"title":"Saliva-Friend and Foe in the COVID-19 Outbreak.","text":["Saliva-Friend and Foe in the COVID-19 Outbreak.","The coronavirus disease 2019 (COVID-19) outbreak, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global ongoing pandemic. Timely, accurate and non-invasive SARS-CoV-2 detection in both symptomatic and asymptomatic patients, as well as determination of their immune status, will facilitate effective large-scale pandemic control measures to prevent the spread of COVID-19. Saliva is a biofluid whose anatomical source and location is of particularly strategic relevance to COVID-19 transmission and monitoring. This review focuses on the role of saliva as both a foe (a common mode of viral transmission via salivary droplets and potentially aerosols) and a friend (as a non-invasive diagnostic tool for viral detection and immune status surveillance) in combating COVID-19.","Diagnostics (Basel)","Han, Pingping","Ivanovski, Saso","32397487"],"abstract":["The coronavirus disease 2019 (COVID-19) outbreak, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global ongoing pandemic. Timely, accurate and non-invasive SARS-CoV-2 detection in both symptomatic and asymptomatic patients, as well as determination of their immune status, will facilitate effective large-scale pandemic control measures to prevent the spread of COVID-19. Saliva is a biofluid whose anatomical source and location is of particularly strategic relevance to COVID-19 transmission and monitoring. This review focuses on the role of saliva as both a foe (a common mode of viral transmission via salivary droplets and potentially aerosols) and a friend (as a non-invasive diagnostic tool for viral detection and immune status surveillance) in combating COVID-19."],"journal":"Diagnostics (Basel)","authors":["Han, Pingping","Ivanovski, Saso"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32397487","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3390/diagnostics10050290","keywords":["covid-19","salivary bioaerosols transmission","salivary diagnostics"],"topics":["Diagnosis"],"weight":1,"_version_":1666865855032459264,"score":47.671585},{"pmid":32461671,"title":"Innate T cells in COVID-19: friend or foe?","text":["Innate T cells in COVID-19: friend or foe?","Nat Rev Immunol","van der Heide, Verena","32461671"],"journal":"Nat Rev Immunol","authors":["van der Heide, Verena"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32461671","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1038/s41577-020-0349-7","topics":["Mechanism"],"weight":1,"_version_":1668079521424736256,"score":47.671585},{"pmid":32471815,"title":"Epinephrine use in COVID-19: friend or foe?","text":["Epinephrine use in COVID-19: friend or foe?","Eur J Hosp Pharm","Luo, Pan","Liu, Dong","Li, Juan","32471815"],"journal":"Eur J Hosp Pharm","authors":["Luo, Pan","Liu, Dong","Li, Juan"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32471815","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/ejhpharm-2020-002295","keywords":["infection control","infectious diseases & infestations","intensive & critical care","pathology","pharmacology"],"weight":0,"_version_":1668255193366528001,"score":47.671585}]}